Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
An announcement from Sinco Pharmaceuticals Holdings Ltd. ( (HK:6833) ) is now available.
Sinco Pharmaceuticals Holdings Ltd. held an Extraordinary General Meeting on 26 May 2025, where all proposed resolutions were approved by shareholders. The resolutions included the implementation of a new 2025 Share Option Scheme, the authorization to issue new shares, and the termination of the existing share option scheme from 2016. The approval of these resolutions is expected to enhance the company’s operational flexibility and align its share option schemes with current market practices.
More about Sinco Pharmaceuticals Holdings Ltd.
Sinco Pharmaceuticals Holdings Ltd. is a company incorporated under the laws of the Cayman Islands, operating in the pharmaceutical industry. The company is listed on the Hong Kong Stock Exchange and focuses on developing and providing pharmaceutical products.
Average Trading Volume: 530,222
Technical Sentiment Signal: Sell
Current Market Cap: HK$374.1M
For detailed information about 6833 stock, go to TipRanks’ Stock Analysis page.